SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marcello Maida, Giuseppe Cabibbo, Giuseppe Brancatelli, Chiara Genco, Nicola Alessi, Claudio Genova, Piero Romano, Maurizio Raineri, Antonello Giarratano, Massimo Midiri, Calogero Cammà, Assessment of treatment response in hepatocellular carcinoma: a review of the literature, Future Oncology, 2013, 9, 6, 845

    CrossRef

  2. 2
    Mausumi Bharadwaj, Gaurav Roy, Koushik Dutta, Mohammad Misbah, Mohammad Husain, Showket Hussain, Tackling hepatitis B virus-associated hepatocellular carcinoma—the future is now, Cancer and Metastasis Reviews, 2013, 32, 1-2, 229

    CrossRef

  3. 3
    Morito Monden, Masato Sakon, Yuh Sakata, Yoshitaka Ueda, Etsuro Hashimura, 5-fluorouracil arterial infusion + interferon therapy for highly advanced hepatocellular carcinoma: A multicenter, randomized, phase II study, Hepatology Research, 2012, 42, 2
  4. 4
    Nazneen Dubey, Raunak Varshney, Jaya Shukla, Aditya Ganeshpurkar, Puja P. Hazari, Guru P. Bandopadhaya, Anil K. Mishra, Piyush Trivedi, Synthesis and evaluation of biodegradable PCL/PEG nanoparticles for neuroendocrine tumor targeted delivery of somatostatin analog, Drug Delivery, 2012, 19, 3, 132

    CrossRef

  5. 5
    Nuh N. Rahbari, Arianeb Mehrabi, Nathan M. Mollberg, Sascha A. Müller, Moritz Koch, Markus W. Büchler, Jürgen Weitz, Hepatocellular Carcinoma, Annals of Surgery, 2011, 253, 3, 453

    CrossRef

  6. 6
    Xi-Qing Ji, Xin-Jian Ruan, Hong Chen, Gang Chen, Shi-Yong Li, Bo Yu, Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials, Medical Science Monitor, 2011, 17, 8, RA169

    CrossRef

  7. 7
    Ponni V. Perumalswami, Thomas D. Schiano, The Management of Hospitalized Patients with Cirrhosis: The Mount Sinai Experience and a Guide for Hospitalists, Digestive Diseases and Sciences, 2011, 56, 5, 1266

    CrossRef

  8. 8
    Maria Georgiadou, George Notas, Costas Xidakis, Ioannis Drygiannakis, Ourania Sfakianaki, Stefanos Klironomos, Vassilis Valatas, Elias Kouroumalis, TNF receptors in Kupffer cells, Journal of Receptors and Signal Transduction, 2011, 31, 4, 291

    CrossRef

  9. 9
    Giuseppe Cabibbo, Marco Enea, Massimo Attanasio, Jordi Bruix, Antonio Craxì, Calogero Cammà, A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma, Hepatology, 2010, 51, 4
  10. 10
    Jia Liu, Thomas Mittendorf, J.-Matthias von der Schulenburg, A Structured Review and Guide Through Studies on Health-Related Quality of Life in Kidney Cancer, Hepatocellular Carcinoma, and Leukemia, Cancer Investigation, 2010, 28, 3, 312

    CrossRef

  11. You have free access to this content11
    Chapter 4: Chemotherapy and radiotherapy, Hepatology Research, 2010, 40,
  12. 12
    Chiun Hsu, Ying-Chun Shen, Chia-Chi Cheng, Fu-Chang Hu, Ann-Lii Cheng, Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design, Contemporary Clinical Trials, 2010, 31, 1, 55

    CrossRef

  13. 13
    Anna Giacomin, Adriana Sergio, Veronica Vanin, Pietro Tartaro, Daniela Paccagnella, Mauro Mazzucco, Fabio Farinati, Megestrol and embryonic extracts in the treatment of advanced hepatocellular carcinoma: A prospective randomized trial in the pre-sorafenib era, Hepatology Research, 2010, 40, 2
  14. 14
    Alejandro Forner, Carlos Rodríguez De Lope, María Reig, Jordi Bruix, Tratamiento del carcinoma hepatocelular avanzado, Gastroenterología y Hepatología, 2010, 33, 6, 461

    CrossRef

  15. 15
    Alejandro Forner, Carmen Ayuso, María Isabel Real, Javier Sastre, Ricardo Robles, Bruno Sangro, María Varela, Manuel de la Mata, María Buti, Luís Martí-Bonmatí, Concepció Bru, Josep Tabernero, Josep M Llovet, Jordi Bruix, Diagnóstico y tratamiento del carcinoma hepatocelular, Medicina Clínica, 2009, 132, 7, 272

    CrossRef

  16. 16
    Luigi Fenoglio, Elisabetta Castagna, Cristina Serraino, Adele Cardellicchio, Fulvio Pomero, Christian Bracco, Maurizio Grosso, Gestione del carcinoma epatocellulare: le linee guida internazionali, Italian Journal of Medicine, 2009, 3, 3, 136

    CrossRef

  17. 17
    G. Treiber, T. Wex, P. Malfertheiner, Impact of different anticancer regimens on biomarkers of angiogenesis in patients with advanced hepatocellular cancer, Journal of Cancer Research and Clinical Oncology, 2009, 135, 2, 271

    CrossRef

  18. 18
    Tian-Kang Guo, Xiang-Yong Hao, Bin Ma, Ke-Hu Yang, Yi-Ping Li, Hong-Ling Li, Yuan-Hui Gu, Hui Cai, Ya-Li Liu, Yuan Li, Wei-Peng Zhan, Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials, Journal of Cancer Research and Clinical Oncology, 2009, 135, 12, 1685

    CrossRef

  19. 19
    Practice guidelines for management of hepatocellular carcinoma 2009, The Korean Journal of Hepatology, 2009, 15, 3, 391

    CrossRef

  20. 20
    Susana Oquiñena, Francisco Guillen-Grima, Mercedes Iñarrairaegui, Jose M. Zozaya, Bruno Sangro, Spontaneous regression of hepatocellular carcinoma: a systematic review, European Journal of Gastroenterology & Hepatology, 2009, 21, 3, 254

    CrossRef

  21. 21
    Arun AZAD, Fiona CHIONH, Jonathan CEBON, Targeted agents for the systemic treatment of advanced hepatocellular carcinoma, Asia-Pacific Journal of Clinical Oncology, 2009, 5, 2
  22. 22
    Hans Christian Spangenberg, Robert Thimme, Hubert E. Blum, Targeted therapy for hepatocellular carcinoma, Nature Reviews Gastroenterology & Hepatology, 2009, 6, 7, 423

    CrossRef

  23. 23
    Jean-Claude Barbare, Olivier Bouché, Franck Bonnetain, Laetitia Dahan, Catherine Lombard-Bohas, Roger Faroux, Jean-Luc Raoul, Stéphane Cattan, Alain Lemoine, Jean-Frédéric Blanc, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Sophie Cazorla, Dany Gargot, Thierry Thevenot, Emmanuel Diaz, Anne Bastie, Thomas Aparicio, Laurent Bedenne, Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study, European Journal of Cancer, 2009, 45, 10, 1788

    CrossRef

  24. 24
    Anna K NOWAK, Jonathan CEBON, Carol HARGREAVES, Haryana DHILLON, Michael FINDLAY, Val GEBSKI, Martin R STOCKLER, Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma, Asia-Pacific Journal of Clinical Oncology, 2008, 4, 1
  25. 25
    Hashem B. El-Serag, Jorge A. Marrero, Lenhard Rudolph, K. Rajender Reddy, Diagnosis and Treatment of Hepatocellular Carcinoma, Gastroenterology, 2008, 134, 6, 1752

    CrossRef

  26. 26
    Dimitrios N. Samonakis, George Notas, Nikolaos Christodoulakis, Elias A. Kouroumalis, Mechanisms of Action and Resistance of Somatostatin Analogues for the Treatment of Hepatocellular Carcinoma: A Message Not Well Taken, Digestive Diseases and Sciences, 2008, 53, 9, 2359

    CrossRef

  27. 27
    Christian Müller, Maximilian Schöniger-Hekele, Rüdiger Schernthaner, Barbara Renner, Markus Peck-Radosavljevic, Andrea Brichta, Fritz Wrba, Martin Posch, Peter Bauer, Peter Ferenci, Alfred Gangl, Percutaneous ethanol instillation therapy for hepatocellular carcinoma – a randomized controlled trial, Wiener klinische Wochenschrift, 2008, 120, 19-20, 608

    CrossRef

  28. 28
    Chul Ju Han, Recent developments in systemic chemotherapy for hepatocellular carcinoma, The Korean Journal of Hepatology, 2008, 14, 1, 4

    CrossRef

  29. 29
    C. Verhoef, H. van Dekken, L.J. Hofland, P.E. Zondervan, J.H.W. de Wilt, R. van Marion, R.A. de Man, J.N.M. IJzermans, C.H.J. van Eijck, Somatostatin Receptor in Human Hepatocellular Carcinomas: Biological, Patient and Tumor Characteristics, Digestive Surgery, 2008, 25, 1, 21

    CrossRef

  30. 30
    Patricia Roxburgh, T. R. Jeffry Evans, Systemic therapy of hepatocellular carcinoma: Are we making progress?, Advances in Therapy, 2008, 25, 11, 1089

    CrossRef

  31. 31
    Frédéric Borie, Anne-Marie Bouvier, Astrid Herrero, Jean Faivre, Guy Launoy, Patricia Delafosse, Michel Velten, Antoine Buemi, Jun Peng, Pascale Grosclaude, Brigitte Trétarre, Treatment and prognosis of hepatocellular carcinoma: A population based study in France, Journal of Surgical Oncology, 2008, 98, 7
  32. 32
    Dalbir S Sandhu, Vivek S Tharayil, Jin-Ping Lai, Lewis R Roberts, Treatment options for hepatocellular carcinoma, Expert Review of Gastroenterology & Hepatology, 2008, 2, 1, 81

    CrossRef

  33. 33
    G. Becker, A. Schmitt-Graeff, V. Ertelt, H.E. Blum, H.-P. Allgaier, CD117 (c-kit) Expression in Human Hepatocellular Carcinoma, Clinical Oncology, 2007, 19, 3, 204

    CrossRef

  34. 34
    G Verset, C Verslype, H Reynaert, I Borbath, P Langlet, A Vandebroek, M Peeters, G Houbiers, S Francque, M Arvanitakis, J-L Van Laethem, Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study, British Journal of Cancer, 2007, 97, 5, 582

    CrossRef

  35. 35
    Philippe Rougier, Emmanuel Mitry, Jean-Claude Barbare, Julien Taieb, Hepatocellular Carcinoma (HCC): An Update, Seminars in Oncology, 2007, 34, S12

    CrossRef

  36. 36
    Ivan Borbath, Isabelle A. Leclercq, Jorge Abarca-Quinones, Christine Desaeger, Valérie Lebrun, Pierre Moulin, Christine Sempoux, Yves Horsmans, Inhibition of early preneoplastic events in the rat liver by the somatostatin analog lanreotide, Cancer Science, 2007, 98, 12
  37. 37
    Jonathan Schwartz, LONG-ACTING OCTREOTIDE FOR ADVANCED LIVER CANCER: A WELL-DESIGNED NEGATIVE TRIAL, Evidence-Based Gastroenterology, 2007, 8, 2, 43

    CrossRef

  38. 38
    Gerhild Becker, Hans-Peter Allgaier, Manfred Olschewski, Andreas Zähringer, Hubert Erich Blum, Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study, Hepatology, 2007, 45, 1
  39. 39
    Ying Chun Shen, Chiun Hsu, Ann Lii Cheng, Molecular targeted therapy for advanced hepatocellular carcinoma, Targeted Oncology, 2007, 2, 4, 199

    CrossRef

  40. 40
    George Notas, Marilena Kampa, Artemissia-Phoebe Nifli, Kostas Xidakis, Despoina Papasava, Kyriaki Thermos, Elias Kouroumalis, Elias Castanas, The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptors, European Journal of Pharmacology, 2007, 555, 1, 1

    CrossRef

  41. 41
    Pierre Chan, Ching Lai, Man Yuen, Gastrointestinal Oncology, 2007,

    CrossRef

  42. 42
    Christian Müller, Hepatocellular carcinoma – Rising incidence, changing therapeutic strategies, Wiener Medizinische Wochenschrift, 2006, 156, 13-14, 404

    CrossRef

  43. 43
    Jean-Claude Barbare, Valérie Boige, Karim Boudjema, Robin Lescesne, Jean-Claude Trinchet, Hepatocellular carcinoma (primary cancer of the liver), Gastroentérologie Clinique et Biologique, 2006, 30, 57

    CrossRef

  44. 44
    Shiv K Sarin, Manoj Kumar, Sanjay Garg, Syed Hissar, Chandana Pandey, Barjesh C Sharma, High dose vitamin K3 infusion in advanced hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2006, 21, 9
  45. 45
    Dimitrios N Samonakis, Nikolaos Christodoulakis, Elias A Kouroumalis, Octreotide for Unresectable Hepatocellular Carcinoma: Beyond the First Sight, Journal of Clinical Gastroenterology, 2006, 40, 1, 86

    CrossRef

  46. 46
    H. Cerwenka, H. Bacher, H.-J. Mischinger, Primary hepatoma – guidelines for interdisciplinary treatment, European Surgery, 2006, 38, 2, 94

    CrossRef

  47. 47
    J Cebon, Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide, British Journal of Cancer, 2006, 95, 7, 853

    CrossRef

  48. 48
    Seth J Karp, Yonson Ku, Scott Johnson, Khalid Khwaja, Michael Curry, Douglas Hanto, Surgical and non-surgical approaches to hepatocellular cancer, Current Opinion in Organ Transplantation, 2006, 11, 3, 226

    CrossRef

  49. 49
    P. M. LOPEZ, A. VILLANUEVA, J. M. LLOVET, Systematic review: evidence-based management of hepatocellular carcinoma – an updated analysis of randomized controlled trials, Alimentary Pharmacology & Therapeutics, 2006, 23, 11
  50. 50
    Michel Doffoël, Ahmed Ananna, Traitement palliatif du carcinome hépatocellulaire, Gastroentérologie Clinique et Biologique, 2006, 30, 6-7, 887

    CrossRef

  51. 51
    Alejandro Forner, Amelia J. Hessheimer, M. Isabel Real, Jordi Bruix, Treatment of hepatocellular carcinoma, Critical Reviews in Oncology/Hematology, 2006, 60, 2, 89

    CrossRef

  52. 52
    Annemarie Musch, Christian Rabe, Mignon-Denise Paik, Marc Jean Berna, Volker Schmitz, Per Hoffmann, Hans Dieter Nischalke, Tilman Sauerbruch, Wolfgang H. Caselmann, Altered Expression of TGF-β Receptors in Hepatocellular Carcinoma – Effects of a Constitutively Active TGF-β Type I Receptor Mutant, Digestion, 2005, 71, 2, 78

    CrossRef

  53. 53
    Philip J. Johnson, Lucinda J. Billingham, Clinical trial design in hepatocellular carcinoma, Best Practice & Research Clinical Gastroenterology, 2005, 19, 1, 119

    CrossRef

  54. 54
    Daniel H Palmer, Syed A Hussain, Philip J Johnson, Gene- and immunotherapy for hepatocellular carcinoma, Expert Opinion on Biological Therapy, 2005, 5, 4, 507

    CrossRef

  55. 55
    RUBEN R PLENTZ, HANS L TILLMANN, STEFAN KUBICKA, JÖRG S BLECK, MICHAEL GEBEL, MICHAEL P MANNS, KARL L RUDOLPH, Hepatocellular carcinoma and octreotide: Treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage, Journal of Gastroenterology and Hepatology, 2005, 20, 9
  56. 56
    Mary F. Mulcahy, Management of hepatocellular cancer, Current Treatment Options in Oncology, 2005, 6, 5, 423

    CrossRef

  57. 57
    Jordi Bruix, Morris Sherman, Management of hepatocellular carcinoma, Hepatology, 2005, 42, 5
  58. 58
    Yuk Pang Yeung, Chung Mau Lo, Chi Leung Liu, Benjamin C. Wong, Sheung Tat Fan, John Wong, Natural History of Untreated Nonsurgical Hepatocellular Carcinoma, The American Journal of Gastroenterology, 2005, 100, 9, 1995

    CrossRef

  59. 59
    PHILIP J. JOHNSON, Non-surgical treatment of hepatocellular carcinoma, HPB, 2005, 7, 1
  60. 60
    Wilco A Slijkhuis, Linda Stadheim, Ziad M Hassoun, Ugochukwu C Nzeako, Walter K Kremers, Jayant A Talwalkar, Gregory J Gores, Octreotide Therapy for Advanced Hepatocellular Carcinoma, Journal of Clinical Gastroenterology, 2005, 39, 4, 333

    CrossRef

  61. 61
    Michel Beaugrand, Jean-Claude Trinchet, Traitement non chirurgical du carcinome hépatocellulaire. Une vision d'ensemble, Cancer/Radiothérapie, 2005, 9, 6-7, 464

    CrossRef

  62. 62
    Hubert E. Blum, Treatment of hepatocellular carcinoma, Best Practice & Research Clinical Gastroenterology, 2005, 19, 1, 129

    CrossRef

  63. 63
    George Notas, George Kolios, Niki Mastrodimou, Marilena Kampa, Anna Vasilaki, Costas Xidakis, Elias Castanas, Kyriaki Thermos, Elias Kouroumalis, Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors, Journal of Hepatology, 2004, 40, 5, 792

    CrossRef

  64. 64
    Jane M. Blazeby, Elspeth Currie, Benny C.Y. Zee, Wei-Chu Chie, Ronnie T. Poon, O. James Garden, Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18, European Journal of Cancer, 2004, 40, 16, 2439

    CrossRef

  65. 65
    Michael Bläker, Michael Schmitz, Andreas Gocht, Sylvia Burghardt, Martina Schulz, Dieter C. Bröring, Andrea Pace, Heiner Greten, Andreas de Weerth, Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas, Journal of Hepatology, 2004, 41, 1, 112

    CrossRef

  66. 66
    Joseph Ahn, Steven L. Flamm, Hepatocellular carcinoma, Disease-a-Month, 2004, 50, 10, 556

    CrossRef

  67. 67
    Mike Cusnir, Yehuda Z. Patt, Novel Systemic Therapy Options for Hepatocellular Carcinoma, The Cancer Journal, 2004, 10, 2, 97

    CrossRef

  68. 68
    Hakan Senturk, Billur Canbakan, Rana Cumali, Regression of a Hepatocellular Carcinoma Following Treatment with Octreotide and Tamoxifen in a Patient with Advanced Alcoholic Cirrhosis, Journal of Gastroenterology and Hepatology, 2004, 19, 6
  69. 69
    Daniel H Palmer, Syed A Hussain, Philip J Johnson, Systemic therapies for hepatocellular carcinoma, Expert Opinion on Investigational Drugs, 2004, 13, 12, 1555

    CrossRef

  70. 70
    Anna K Nowak, Pierce K.H Chow, Michael Findlay, Systemic therapy for advanced hepatocellular carcinoma: a review, European Journal of Cancer, 2004, 40, 10, 1474

    CrossRef

  71. 71
    Andrew Burroughs, Daniel Hochhauser, Tim Meyer, Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum, The Lancet Oncology, 2004, 5, 7, 409

    CrossRef

  72. 72
    Jonathan D. Schwartz, Andreas S. Beutler, Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials???II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma, Anti-Cancer Drugs, 2004, 15, 5, 439

    CrossRef

  73. 73
    I. Hourmand-Ollivier, L. Chiche, Traitement du carcinome hépatocellulaire sur cirrhose, Journal de Chirurgie, 2004, 141, 2, 71

    CrossRef

  74. 74
    Beatrice Gerard, Harry Bleiberg, Treatment of hepatocarcinoma, Current Oncology Reports, 2004, 6, 3, 184

    CrossRef

  75. 75
    R Mazzanti, A.L Giallombardo, E Mini, S Nobili, B Neri, U Arena, P Pantaleo, V Fabbroni, M Ghilardi, R Gattai, L Bandettini, Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study, Digestive and Liver Disease, 2004, 36, 4, 278

    CrossRef

  76. 76
    Christian Rabe, Matthias Lenz, Volker Schmitz, Tillmann Pilz, Rolf Fimmers, Tilman Sauerbruch, Wolfgang H Caselmann, An independent evaluation of modern prognostic scores in a central European cohort of 120 patients with hepatocellular carcinoma, European Journal of Gastroenterology & Hepatology, 2003, 15, 12, 1305

    CrossRef

  77. 77
    Jorge A. Marrero, Hepatocellular carcinoma, Current Opinion in Gastroenterology, 2003, 19, 3, 243

    CrossRef

  78. 78
    Josep M Llovet, Andrew Burroughs, Jordi Bruix, Hepatocellular carcinoma, The Lancet, 2003, 362, 9399, 1907

    CrossRef

  79. 79
    Josep M Llovet, Michel Beaugrand, Hepatocellular carcinoma: present status and future prospects, Journal of Hepatology, 2003, 38, 136

    CrossRef

  80. 80
    John F Perry, Simone I Strasser, Jacob George, Geoffrey C Farrell, Geoffrey W McCaughan, Pharmacotherapy of hepatocellular carcinoma, Expert Opinion on Pharmacotherapy, 2003, 4, 12, 2175

    CrossRef

  81. 81
    Jonathan M. Schwartz, John M. Ham, Treatment of hepatocellular carcinoma, Current Treatment Options in Gastroenterology, 2003, 6, 6, 465

    CrossRef